Shanghai Payne Pharmaceutical Technology Co.,Ltd

Business Type:Manufacturer

Main Products:Afatinib (diMaleate),Afatinib (diMaleate),Baricitinib,Regorafenib,Regorafenib monohydrate,Fostamatinib,R-406,LEE011,LEE011 (succinate),4,6-Dimethyl-2-mercaptopyrimidine,4,6-Dimethyl-2-methylsulfonylpyrimidine,7-NITRO-QUINOLINE,4-NITROPHENYLACETYLENE,sofosbuvir impurity

Country/Region:China

Annual Revenue:5000000 RMB

Year Established:2012

Main Markets:South America,Southeast Asia,Africa,Mid East,Eastern Asia,

Ddu Verified

HOT Rank

8/10
Company Information

Shanghai Payne Pharmaceutical Technology Co.,Ltd. is specialized in the design and sales of Pharmaceutical intermediates, APIs, New drug impurity reference. Technology Development and Transfer for Pharmaceutical intermediates and APIs.
Our business and service include: anti – infective, Anti-virus, anti-tumor, Cardiovascular, nervous system, Anti rheumatoid, digestive system ect.

We have the strong advantage of scientific research and development, pilot production, industrial production. The company has a group of synthetic process engineers including doctors and masters with higher attainments. At paynepharma, you will receive high-quality products and service – plus an attractive added value: You can be completely relaxed when you work with paynepharma. Every employee at paynepharma is dedicated to defect-free work, following established procedures, and delivering products and services that are excellent. And because we never stop looking for ways to make things better and to open up new business areas for you.

We sincerely welcome customers from all over the world to cooperate with us and build up a bright future together!


Email to this supplier
To

Send

Inquiry Cart(0)